Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
J Korean Med Sci ; 37(20): e160, 2022 May 23.
Article in English | MEDLINE | ID: covidwho-1862585

ABSTRACT

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 that may trigger Guillain-Barre syndrome (GBS) in selected patients. We describe a case of GBS presenting as marked finger extensor weakness in a 73-year-old woman with COVID-19. Her clinical and electrophysiological findings were consistent with a diagnosis of acute motor axonal neuropathy subtype of GBS with prominent finger dropping. Treatment with intravenous immunoglobulin for 5 days completely resolved her finger extension weakness after 19 months, although other involved extremities recovered earlier at 3 months. This study highlights that COVID-19-associated GBS can present in various forms aside from the classic variant, even in patients without any COVID-19 symptoms. Therefore, it is important to always consider the diagnosis of GBS in patients with COVID-19.


Subject(s)
COVID-19 , Guillain-Barre Syndrome , Aged , COVID-19/complications , Female , Guillain-Barre Syndrome/complications , Guillain-Barre Syndrome/diagnosis , Humans , Immunoglobulins, Intravenous/therapeutic use , Muscle Weakness , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL